Niels W Schurink1,2, Lisa A Min1,2, Maaike Berbee2,3, Wouter van Elmpt2,3, Joost J M van Griethuysen1,2, Frans C H Bakers4, Sander Roberti5, Simon R van Kranen6, Max J Lahaye1, Monique Maas1, Geerard L Beets2,7, Regina G H Beets-Tan1,2, Doenja M J Lambregts8. 1. Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. 2. GROW School for Oncology and Developmental Biology, University of Maastricht, Maastricht, The Netherlands. 3. Department of Radiation Oncology (Maastro Clinic), Maastricht University Medical Centre, Maastricht, The Netherlands. 4. Department of Radiology, Maastricht University Medical Center, Maastricht, The Netherlands. 5. Department of Epidemiology and Biostatistics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. 6. Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. 7. Department of Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands. 8. Department of Radiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. d.lambregts@nki.nl.
Abstract
OBJECTIVES: To explore the value of multiparametric MRI combined with FDG-PET/CT to identify well-responding rectal cancer patients before the start of neoadjuvant chemoradiation. METHODS: Sixty-one locally advanced rectal cancer patients who underwent a baseline FDG-PET/CT and MRI (T2W + DWI) and received long-course neoadjuvant chemoradiotherapy were retrospectively analysed. Tumours were delineated on MRI and PET/CT from which the following quantitative parameters were calculated: T2W volume and entropy, ADC mean and entropy, CT density (mean-HU), SUV maximum and mean, metabolic tumour volume (MTV42%) and total lesion glycolysis (TLG). These features, together with sex, age, mrTN-stage ("baseline parameters") and the CRT-surgery interval were analysed using multivariable stepwise logistic regression. Outcome was a good (TRG 1-2) versus poor histopathological response. Performance (AUC) to predict response was compared for different combinations of baseline ± quantitative imaging parameters and performance in an 'independent' dataset was estimated using bootstrapped leave-one-out cross-validation (LOOCV). RESULTS: The optimal multivariable prediction model consisted of a combination of baseline + quantitative imaging parameters and included mrT-stage (OR 0.004, p < 0.001), T2W-signal entropy (OR 7.81, p = 0.0079) and T2W volume (OR 1.028, p = 0.0389) as the selected predictors. AUC in the study dataset was 0.88 and 0.83 after LOOCV. No PET/CT features were selected as predictors. CONCLUSIONS: A multivariable model incorporating mrT-stage and quantitative parameters from baseline MRI can aid in identifying well-responding patients before the start of treatment. Addition of FDG-PET/CT is not beneficial. KEY POINTS: • A multivariable model incorporating the mrT-stage and quantitative features derived from baseline MRI can aid in identifying well-responding patients before the start of neoadjuvant chemoradiotherapy. • mrT-stage was the strongest predictor in the model and was complemented by the tumour volume and signal entropy calculated from T2W-MRI. • Adding quantitative features derived from pre-treatment PET/CT or DWI did not contribute to the model's predictive performance.
OBJECTIVES: To explore the value of multiparametric MRI combined with FDG-PET/CT to identify well-responding rectal cancerpatients before the start of neoadjuvant chemoradiation. METHODS: Sixty-one locally advanced rectal cancerpatients who underwent a baseline FDG-PET/CT and MRI (T2W + DWI) and received long-course neoadjuvant chemoradiotherapy were retrospectively analysed. Tumours were delineated on MRI and PET/CT from which the following quantitative parameters were calculated: T2W volume and entropy, ADC mean and entropy, CT density (mean-HU), SUV maximum and mean, metabolic tumour volume (MTV42%) and total lesion glycolysis (TLG). These features, together with sex, age, mrTN-stage ("baseline parameters") and the CRT-surgery interval were analysed using multivariable stepwise logistic regression. Outcome was a good (TRG 1-2) versus poor histopathological response. Performance (AUC) to predict response was compared for different combinations of baseline ± quantitative imaging parameters and performance in an 'independent' dataset was estimated using bootstrapped leave-one-out cross-validation (LOOCV). RESULTS: The optimal multivariable prediction model consisted of a combination of baseline + quantitative imaging parameters and included mrT-stage (OR 0.004, p < 0.001), T2W-signal entropy (OR 7.81, p = 0.0079) and T2W volume (OR 1.028, p = 0.0389) as the selected predictors. AUC in the study dataset was 0.88 and 0.83 after LOOCV. No PET/CT features were selected as predictors. CONCLUSIONS: A multivariable model incorporating mrT-stage and quantitative parameters from baseline MRI can aid in identifying well-responding patients before the start of treatment. Addition of FDG-PET/CT is not beneficial. KEY POINTS: • A multivariable model incorporating the mrT-stage and quantitative features derived from baseline MRI can aid in identifying well-responding patients before the start of neoadjuvant chemoradiotherapy. • mrT-stage was the strongest predictor in the model and was complemented by the tumour volume and signal entropy calculated from T2W-MRI. • Adding quantitative features derived from pre-treatment PET/CT or DWI did not contribute to the model's predictive performance.
Authors: Anna Margherita Maffione; Maria Cristina Marzola; Carlo Capirci; Patrick M Colletti; Domenico Rubello Journal: AJR Am J Roentgenol Date: 2015-06 Impact factor: 3.959
Authors: Luís Curvo-Semedo; Doenja M J Lambregts; Monique Maas; Thomas Thywissen; Rana T Mehsen; Guido Lammering; Geerard L Beets; Filipe Caseiro-Alves; Regina G H Beets-Tan Journal: Radiology Date: 2011-06-14 Impact factor: 11.105
Authors: E Akgun; C Caliskan; O Bozbiyik; T Yoldas; M Sezak; S Ozkok; T Kose; B Karabulut; M Harman; O Ozutemiz Journal: Br J Surg Date: 2018-08-29 Impact factor: 6.939
Authors: Carlo N De Cecco; Balaji Ganeshan; Maria Ciolina; Marco Rengo; Felix G Meinel; Daniela Musio; Francesca De Felice; Nicola Raffetto; Vincenzo Tombolini; Andrea Laghi Journal: Invest Radiol Date: 2015-04 Impact factor: 6.016
Authors: Dalton A Dos Anjos; Rodrigo O Perez; Angelita Habr-Gama; Guilherme P São Julião; Bruna B Vailati; Laura M Fernandez; João B de Sousa; Carlos A Buchpiguel Journal: Dis Colon Rectum Date: 2016-09 Impact factor: 4.585
Authors: Angelita Habr-Gama; Joaquim Gama-Rodrigues; Guilherme P São Julião; Igor Proscurshim; Charles Sabbagh; Patricio B Lynn; Rodrigo O Perez Journal: Int J Radiat Oncol Biol Phys Date: 2014-02-01 Impact factor: 7.038
Authors: Niels W Schurink; Simon R van Kranen; Maaike Berbee; Wouter van Elmpt; Frans C H Bakers; Sander Roberti; Joost J M van Griethuysen; Lisa A Min; Max J Lahaye; Monique Maas; Geerard L Beets; Regina G H Beets-Tan; Doenja M J Lambregts Journal: Eur Radiol Date: 2021-02-10 Impact factor: 5.315